ORIC CIK: 1796280

Oric Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
241
FY22:
210
FY23:
213
FY24:
262
FY25:
288
(positive)
Change from FY21 to FY25
millions USD
FY21:
58.1
FY22:
36.7
FY23:
39.4
FY24:
11.9
FY25:
120
Total assets
Change from FY21 to FY25
millions USD
FY21:
299
FY22:
247
FY23:
252
FY24:
274
FY25:
409

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
15.2
FY22:
15.4
FY23:
20.5
FY24:
24.8
FY25:
20.4
(negative)
Change from FY21 to FY25
millions USD
FY21:
10.5
FY22:
9.44
FY23:
7.46
FY24:
6.17
FY25:
4.11
(positive)
Change from FY21 to FY25
millions USD
FY21:
273
FY22:
222
FY23:
224
FY24:
243
FY25:
384
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
299
FY22:
247
FY23:
252
FY24:
274
FY25:
409

All amounts in millions USD Data source:SEC EDGAR